Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients

Summary

This is a phase 4, single center, randomized, open-labeled study. The primary objective of the study is to compare effect of gemigliptin and acarbose on endothelial function. Subjects are randomized to gemigliptin or acarbose group and maintained intial treatment for 4 weeks.

Timeline

Start

2014-09

Primary completion

2015-12

Completion

—

Drugs

Indications